Plasmodium vivax
Conditions
Interventions
This is a sequential mixed-methods study consisting of three interdependent phases conducted in the state of Amazonas, Brazil, including initially the municipalities of Manaus and Ipixuna. The first p
I02.233.332
L01.313.500
Sponsors
Fundação de Medicina Tropical do Amazonas - FMT/IMT/AM
Fundação de Medicina Tropical do Amazonas - FMT/IMT/AM
Eligibility
Age
16 Years to No maximum
Inclusion criteria
Inclusion criteria: Aged 16 years or older at the time of enrollment; Laboratory-confirmed diagnosis of uncomplicated Plasmodium vivax malaria; Prescribed a chloroquine and primaquine daily treatment regimen according to national guidelines; Access to a personal mobile phone capable of receiving SMS or WhatsApp messages; Provided written informed consent before study participation
Exclusion criteria
Exclusion criteria: Diagnosis of severe malaria or infection with non-P. vivax species; Inability to provide informed consent due to severe cognitive impairment; No access to a mobile phone capable of receiving SMS or WhatsApp messages; Known contraindications or allergies to chloroquine or primaquine; Residence outside the study's catchment area where follow-up is not feasible
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to observe treatment adherence between days 7 and 12 after treatment initiation, determined by the 4-item Morisky Medication Adherence Scale (MMAS-4) | — |
Secondary
| Measure | Time frame |
|---|---|
| It has no secondary outcome | — |
Countries
Brazil
Contacts
Public ContactErica Carvalho
Fundacão de Medicina Tropical Heitor Vieira Dourado
Outcome results
None listed